Victory Capital Management Inc Spring Works Therapeutics, Inc. Transaction History

Victory Capital Management Inc

$99 Billion
Q3 2024

A detailed history of Victory Capital Management Inc transactions in Spring Works Therapeutics, Inc. stock. As of the latest transaction made, Victory Capital Management Inc holds 629,387 shares of SWTX stock, worth $22.8 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

629,387

Previous 525,983 19.66%

Holding current value

$22.8 Million

Previous $19.8 Million 1.78%

% of portfolio

0.02%

Previous 0.02%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	BUY	$32.04 - $42.76 $3.31 Million - $4.42 Million	103,404 Added 19.66%	629,387 $20.2 Million
Q2 2024 Aug 05, 2024	BUY	$36.06 - $47.62 $672,591 - $888,208	18,652 Added 3.68%	525,983 $19.8 Million
Q1 2024 May 03, 2024	BUY	$36.5 - $52.5 $5.04 Million - $7.24 Million	137,964 Added 37.35%	507,331 $25 Million
Q4 2023 Feb 05, 2024	BUY	$18.94 - $37.24 $6.21 Million - $12.2 Million	328,127 Added 795.65%	369,367 $13.5 Million
Q3 2023 Nov 06, 2023	BUY	$23.12 - $31.38 $953,468 - $1.29 Million	41,240 New	41,240 $953,000
Q1 2023 May 02, 2023	SELL	$24.97 - $34.05 $3.58 Million - $4.88 Million	-143,461 Reduced 21.74%	516,352 $13.3 Million
Q4 2022 Feb 09, 2023	SELL	$21.73 - $28.72 $6.02 Million - $7.95 Million	-276,934 Reduced 29.56%	659,813 $17.2 Million
Q3 2022 Nov 02, 2022	SELL	$24.1 - $39.66 $1.03 Million - $1.7 Million	-42,847 Reduced 4.37%	936,747 $26.7 Million
Q2 2022 Aug 01, 2022	BUY	$18.36 - $60.07 $3.63 Million - $11.9 Million	197,477 Added 25.25%	979,594 $24.1 Million
Q1 2022 May 04, 2022	BUY	$48.97 - $65.46 $384,071 - $513,402	7,843 Added 1.01%	782,117 $44.1 Million
Q4 2021 Feb 07, 2022	SELL	$53.3 - $75.84 $2.93 Million - $4.16 Million	-54,911 Reduced 6.62%	774,274 $48 Million
Q3 2021 Nov 02, 2021	SELL	$62.66 - $88.26 $2.72 Million - $3.83 Million	-43,377 Reduced 4.97%	829,185 $52.6 Million
Q2 2021 Aug 03, 2021	BUY	$67.45 - $85.63 $1.84 Million - $2.34 Million	27,297 Added 3.23%	872,562 $71.9 Million
Q1 2021 May 04, 2021	BUY	$65.1 - $93.59 $12.8 Million - $18.5 Million	197,361 Added 30.46%	845,265 $62.2 Million
Q4 2020 Feb 01, 2021	BUY	$48.36 - $77.92 $5.07 Million - $8.18 Million	104,920 Added 19.32%	647,904 $47 Million
Q3 2020 Nov 09, 2020	BUY	$36.14 - $51.99 $18.1 Million - $26.1 Million	501,644 Added 1213.46%	542,984 $25.9 Million
Q2 2020 Aug 07, 2020	SELL	$22.98 - $48.57 $2.37 Million - $5 Million	-102,989 Reduced 71.36%	41,340 $1.74 Million
Q1 2020 May 04, 2020	SELL	$20.44 - $41.21 $51,713 - $104,261	-2,530 Reduced 1.72%	144,329 $3.9 Million
Q4 2019 Feb 06, 2020	SELL	$17.74 - $39.52 $32,872 - $73,230	-1,853 Reduced 1.25%	146,859 $5.65 Million
Q4 2019 Feb 04, 2020	SELL	$17.74 - $39.52 $466,349 - $1.04 Million	-26,288 Reduced 15.02%	148,712 $4.68 Million
Q3 2019 Nov 12, 2019	BUY	$18.8 - $27.82 $3.29 Million - $4.87 Million	175,000 New	175,000 $3.79 Million

Others Institutions Holding SWTX

# of Institutions

240

Shares Held

68.9M

Call Options Held

144K

Put Options Held

257K

View Full List

About SpringWorks Therapeutics, Inc.

Ticker SWTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,401,100
Market Cap $2.26B
Description
SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...

More about SWTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.

Account

Victory Capital Management Inc Spring Works Therapeutics, Inc. Transaction History